- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics of Type 2 Diabetes—Progress and Prospects
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 18, Pages 6842
Publisher
MDPI AG
Online
2020-09-18
DOI
10.3390/ijms21186842
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitors
- (2020) Anna Űrgeová et al. PHARMACOGENOMICS
- Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes
- (2019) Mari Cassol Ferreira et al. Diabetology & Metabolic Syndrome
- GLP1R variant is associated with response to exenatide in overweight Chinese Type 2 diabetes patients
- (2019) Mingjun Yu et al. PHARMACOGENOMICS
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
- (2019) Marc Foretz et al. Nature Reviews Endocrinology
- GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome
- (2019) Kadri Seppa et al. Scientific Reports
- Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia
- (2019) R. V. Kapustin et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Genetic Variants inCPA6andPRPF31Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes
- (2018) Daniel M. Rotroff et al. DIABETES
- Incretin hormones: Their role in health and disease
- (2018) Michael A. Nauck et al. DIABETES OBESITY & METABOLISM
- Genomic insights into the causes of type 2 diabetes
- (2018) Claudia Langenberg et al. LANCET
- Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes
- (2018) Edith Pascale Mofo Mato et al. MEDICINE
- Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study
- (2018) V. Chedid et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus
- (2018) Hector E. Sanchez-Ibarra et al. Frontiers in Pharmacology
- DNA methylation in the pathogenesis of type 2 diabetes in humans
- (2018) Cajsa Davegårdh et al. Molecular Metabolism
- A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
- (2018) Maria J. Pereira et al. Diabetes Therapy
- A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
- (2018) Maria J. Pereira et al. Diabetes Therapy
- Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome
- (2018) Manabu Kondo et al. DIABETOLOGIA
- Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome
- (2018) Maarja Toots et al. Scientific Reports
- Identification of Novel Candidate Markers of Type 2 Diabetes and Obesity in Russia by Exome Sequencing with a Limited Sample Size
- (2018) Yury Barbitoff et al. Genes
- Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
- (2018) Gaia Chiara Mannino et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes
- (2018) Wolfgang Rathmann et al. DIABETOLOGIA
- Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs
- (2018) Barbara Capuani et al. Frontiers in Endocrinology
- Transporters Involved in Metformin Pharmacokinetics and Treatment Response
- (2017) Xiaomin Liang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The How-To for Type 2
- (2017) Seliece Dodds NURSING CLINICS OF NORTH AMERICA
- Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes
- (2017) Heike Zimdahl et al. Pharmacogenetics and Genomics
- Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes
- (2017) Wen-Ling Liao et al. Oncotarget
- Low statistical power in biomedical science: a review of three human research domains
- (2017) Estelle Dumas-Mallet et al. Royal Society Open Science
- A missense variant inGLP1Rgene is associated with the glycaemic response to treatment with gliptins
- (2016) M. Javorský et al. DIABETES OBESITY & METABOLISM
- Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics
- (2016) Dipali Dhawan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients
- (2016) Linda Zaharenko et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells
- (2016) Katharina Timper et al. GASTROENTEROLOGY
- A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
- (2016) Eugene Han et al. MEDICINE
- Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
- (2016) Kaixin Zhou et al. NATURE GENETICS
- Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus
- (2016) Jazlina Liza Jamaluddin et al. PHARMACOGENOMICS
- The Impacts ofSLC22A1rs594709 andSLC47A1rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients
- (2016) Di Xiao et al. International Journal of Endocrinology
- Progressing From Metformin to Sulfonylureas or Meglitinides
- (2016) Joan S. Grant et al. Workplace Health & Safety
- Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1
- (2016) Tuuli Sedman et al. Journal of Diabetes Research
- Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide Treatment in Obese Patients With Diabetes Mellitus Type 2
- (2016) Daniel Antonio de Luis et al. JOURNAL OF INVESTIGATIVE MEDICINE
- A Common Susceptibility Gene for Type 2 Diabetes Is Associated with Drug Response to a DPP-4 Inhibitor: Pharmacogenomic Cohort in Okinawa Japan
- (2016) Uru Nezu Osada et al. PLoS One
- The CDKAL1 gene is associated with impaired insulin secretion and glucose-related traits: the Cardiometabolic Risk in Chinese (CRC) study
- (2015) Jun Liang et al. CLINICAL ENDOCRINOLOGY
- Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study
- (2015) Mojca Jensterle et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus
- (2015) Hiromi Kan et al. HEPATOLOGY RESEARCH
- Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene
- (2015) Joshua W. Knowles et al. JOURNAL OF CLINICAL INVESTIGATION
- In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans
- (2015) Stephan Francke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor
- (2015) Daniel Antonio de Luis et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
- (2015) Chia-Hung Lin et al. Journal of Diabetes Research
- Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin
- (2014) S Goswami et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- IRS1 G972R Missense Polymorphism Is Associated With Failure to Oral Antidiabetes Drugs in White Patients With Type 2 Diabetes From Italy
- (2014) S. Prudente et al. DIABETES
- The Pharmacogenetics of Type 2 Diabetes: A Systematic Review
- (2014) Nisa M. Maruthur et al. DIABETES CARE
- Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin
- (2014) Heike Zimdahl et al. DIABETOLOGIA
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
- (2014) Jasna Klen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- RS11212617 is associated with metformin treatment response in type 2 diabetes in Shanghai local Chinese population
- (2014) Y. Zhou et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice
- (2014) Lijie Liu et al. Islets
- Response to the dipeptidyl peptidase-4 inhibitors in Japanese patients with type 2 diabetes might be associated with a diplotype of two single nucleotide polymorphisms on the interleukin-6 promoter region under a certain level of physical activity
- (2014) Mizue Matsui et al. Journal of Diabetes Investigation
- Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites (MicroRNAs中与2型糖尿病相关的基因多态性及microRNA靶位)
- (2014) Weijing Gong et al. Journal of Diabetes
- The Role of Genetic Factors and Kidney and Liver Function in Glycemic Control in Type 2 Diabetes Patients on Long-Term Metformin and Sulphonylurea Cotreatment
- (2014) Jasna Klen et al. Biomed Research International
- Influences of Organic Cation Transporter Polymorphisms on the Population Pharmacokinetics of Metformin in Healthy Subjects
- (2013) Hwa Yoon et al. AAPS Journal
- The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway
- (2013) Leen M. ‘t Hart et al. DIABETES
- Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers
- (2013) Christina L. Aquilante et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Variation in KCNQ1 is associated with therapeutic response to sulphonylureas
- (2013) Zbynek Schroner et al. MEDICAL SCIENCE MONITOR
- A gene–gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin
- (2013) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Effects ofNOS1APrs12742393 Polymorphism on Repaglinide Response in Chinese Patients with Type 2 Diabetes Mellitus
- (2013) Tao Wang et al. PHARMACOTHERAPY
- CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62,567 subjects
- (2013) Yan-yan Li et al. Scientific Reports
- Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis
- (2012) K Toyama et al. BRITISH JOURNAL OF PHARMACOLOGY
- KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients
- (2012) Xing-Ping Dai et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
- (2012) S L Stocker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Diabetes-Associated Common Genetic Variation and Its Association With GLP-1 Concentrations and Response to Exogenous GLP-1
- (2012) Galina Smushkin et al. DIABETES
- The C Allele of ATM rs11212617 Does Not Associate With Metformin Response in the Diabetes Prevention Program
- (2012) J. C. Florez et al. DIABETES CARE
- Pharmacogenomic association between a variant inSLC47A1gene and therapeutic response to metformin in type 2 diabetes
- (2012) I. Tkáč et al. DIABETES OBESITY & METABOLISM
- A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
- (2012) N. van Leeuwen et al. DIABETOLOGIA
- Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents
- (2012) C. E. Moss et al. DIABETOLOGIA
- ABCC8 Polymorphisms Are Associated with Triglyceride Concentration in Type 2 Diabetics on Sulfonylurea Therapy
- (2012) Nora Nikolac et al. Genetic Testing and Molecular Biomarkers
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
- (2012) NATURE GENETICS
- Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients
- (2012) Linda Tarasova et al. Pharmacogenetics and Genomics
- Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment
- (2011) Nanna D. Rendtorff et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Voltage-gated K+ channel KCNQ1 regulates insulin secretion in MIN6 β-cell line
- (2011) Kazuya Yamagata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes
- (2011) Andreas Holstein et al. BMC Medical Genetics
- Effect of genetic polymorphisms on the pharmacokinetics and efficacy of glimepiride in a Korean population
- (2011) Hyun-Jung Cho et al. CLINICA CHIMICA ACTA
- Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes
- (2011) W Yu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
- (2011) J H Choi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Does Metformin Work for Everyone? A Genome-wide Association Study for Metformin Response
- (2011) Jose C. Florez Current Diabetes Reports
- SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
- (2011) Michael J. Jurczak et al. DIABETES
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
- (2011) David R. Whiting et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
- (2011) Martin Javorsky et al. European Journal of Internal Medicine
- Variants at the Endocannabinoid Receptor CB1 Gene (CNR1) and Insulin Sensitivity, Type 2 Diabetes, and Coronary Heart Disease
- (2011) Jose M. de Miguel-Yanes et al. Obesity
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- MicroRNA pharmacogenomics: Post-transcriptional regulation of drug response
- (2011) Jakob Lewin Rukov et al. TRENDS IN MOLECULAR MEDICINE
- Effect of genetic polymorphisms on the development of secondary failure to sulfonylurea in Egyptian patients with type 2 diabetes
- (2011) Alaa E. El-sisi et al. Therapeutic Advances in Endocrinology and Metabolism
- A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese
- (2010) Wen Qin et al. ACTA PHARMACOLOGICA SINICA
- KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes
- (2010) M Yu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
- (2010) K. A. Jablonski et al. DIABETES
- Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study
- (2010) A. Sathananthan et al. DIABETES CARE
- Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes
- (2010) Z. Schroner et al. DIABETES OBESITY & METABOLISM
- Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics
- (2010) A. Seeringer et al. DIABETES OBESITY & METABOLISM
- A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse
- (2010) A. Hugill et al. DIABETOLOGIA
- Genetic Polymorphisms in Organic Cation Transporter 1 (OCT1) in Chinese and Japanese Populations Exhibit Altered Function
- (2010) L. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Genotype imputation for genome-wide association studies
- (2010) Jonathan Marchini et al. NATURE REVIEWS GENETICS
- Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea
- (2010) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- Metabolic Control in Type 2 Diabetes Is Associated with Sulfonylurea Receptor-1 (SUR-1) but Not with KCNJ11 Polymorphisms
- (2009) Nora Nikolac et al. ARCHIVES OF MEDICAL RESEARCH
- Current Understanding of the Pharmacogenomics of Metformin
- (2009) O Zolk CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development
- (2009) S.-F. Zhou et al. CURRENT MEDICINAL CHEMISTRY
- Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
- (2009) K. Zhou et al. DIABETES
- Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
- (2009) K. Mussig et al. DIABETES
- Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
- (2009) M. L. Becker et al. DIABETES
- Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
- (2009) Luan Shu et al. HUMAN MOLECULAR GENETICS
- Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity
- (2009) Moto Kajiwara et al. JOURNAL OF HUMAN GENETICS
- Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies
- (2009) Elizabeth B Daily et al. PHARMACOGENOMICS
- Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
- (2009) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Association ofKCNJ11andABCC8genetic polymorphisms with response to repaglinide in Chinese diabetic patients1
- (2008) Ya-yi HE et al. ACTA PHARMACOLOGICA SINICA
- Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
- (2008) IS Song et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Structure/Function Evaluations of Single Nucleotide Polymorphisms in Human N-Acetyltransferase 2
- (2008) Jason Walraven et al. CURRENT DRUG METABOLISM
- Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
- (2008) Y. Feng et al. DIABETES CARE
- Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation
- (2008) Zhengyu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
- (2008) Kazuki Yasuda et al. NATURE GENETICS
- Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
- (2008) Eleftheria Zeggini et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now